$350,000 of EDWARDS LIFESCIENCES LLC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Ensuring Patient Access to Critical Breakthrough Products (H.R.1691 S.5349) Transitional Coverage for Emerging Technologies (TCET) Guidance Policies promoting medical innovation Heart Valve Disease Awareness FDA Reauthorization for 2022/FDA User Fees Diversity in Clinical Trials Coverage with Evidence Development CMS Coverage Policies for Medical Devices CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691/S.5349) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Diversity in Clinical Trials Coverage with Evidence Development Corporate Tax Reform Proposals Tariffs Veterans Access to MedTech"
You can find more data on corporate lobbying on Quiver Quantitative.
EW Congressional Stock Trading
Members of Congress have traded $EW stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $EW stock by members of Congress over the last 6 months:
- REPRESENTATIVE BRUCE WESTERMAN purchased up to $15,000 on 03/03.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
EW Insider Trading Activity
EW insiders have traded $EW stock on the open market 23 times in the past 6 months. Of those trades, 0 have been purchases and 23 have been sales.
Here’s a breakdown of recent trading of $EW stock by insiders over the last 6 months:
- SCOTT B. ULLEM (CVP, Chief Financial Officer) has made 0 purchases and 5 sales selling 45,000 shares for an estimated $3,252,271.
- DONALD E JR BOBO (CVP,Strategy/Corp Development) has made 0 purchases and 7 sales selling 40,500 shares for an estimated $2,831,512.
- LARRY L WOOD (Global President TAVR & Surg) sold 25,000 shares for an estimated $1,647,862
- STEVEN R LORANGER sold 5,739 shares for an estimated $438,575
- HEISZ LESLIE STONE sold 5,739 shares for an estimated $435,370
- BERNARD J ZOVIGHIAN (CEO) sold 6,164 shares for an estimated $428,447
- DANIEL J. LIPPIS (CVP, JAPAC) has made 0 purchases and 5 sales selling 4,200 shares for an estimated $306,722.
- DAVEEN CHOPRA (CVP, TMTT) sold 1,750 shares for an estimated $128,222
- WAYNE MARKOWITZ (GM & SVP, Surgical) sold 583 shares for an estimated $42,716
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EW Hedge Fund Activity
We have seen 463 institutional investors add shares of EW stock to their portfolio, and 637 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JENNISON ASSOCIATES LLC added 7,509,650 shares (+inf%) to their portfolio in Q4 2024, for an estimated $555,939,389
- CITADEL ADVISORS LLC added 7,426,571 shares (+372.9%) to their portfolio in Q4 2024, for an estimated $549,789,051
- VANGUARD GROUP INC added 6,537,494 shares (+10.4%) to their portfolio in Q4 2024, for an estimated $483,970,680
- JPMORGAN CHASE & CO added 6,385,779 shares (+75.4%) to their portfolio in Q4 2024, for an estimated $472,739,219
- SANDS CAPITAL MANAGEMENT, LLC removed 5,320,024 shares (-99.7%) from their portfolio in Q4 2024, for an estimated $393,841,376
- ALLIANCEBERNSTEIN L.P. removed 4,944,582 shares (-70.8%) from their portfolio in Q4 2024, for an estimated $366,047,405
- CIBC PRIVATE WEALTH GROUP LLC removed 2,302,841 shares (-91.1%) from their portfolio in Q4 2024, for an estimated $170,479,319
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
EW Analyst Ratings
Wall Street analysts have issued reports on $EW in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 12/05/2024
- Oppenheimer issued a "Outperform" rating on 12/05/2024
- Goldman Sachs issued a "Buy" rating on 10/30/2024
- Citigroup issued a "Buy" rating on 10/28/2024
To track analyst ratings and price targets for EW, check out Quiver Quantitative's $EW forecast page.
EW Price Targets
Multiple analysts have issued price targets for $EW recently. We have seen 7 analysts offer price targets for $EW in the last 6 months, with a median target of $78.0.
Here are some recent targets:
- Rick Wise from Stifel Nicolaus set a target price of $90.0 on 01/29/2025
- Lee Hambright from Bernstein set a target price of $74.0 on 01/08/2025
- Richard Newitter from Truist Financial set a target price of $78.0 on 12/05/2024
- William Plovanic from Canaccord Genuity set a target price of $68.0 on 12/05/2024
- David Roman from Goldman Sachs set a target price of $80.0 on 10/30/2024
- Travis Steed from Bank of America Securities set a target price of $75.0 on 10/30/2024
- Joanne Wuensch from Citigroup set a target price of $81.0 on 10/28/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
